Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

The LEGEND-D Trial – which aims to prevent low blood sugar levels in type 1 diabetes – is open to recruitment

DTU OCDEM

The first participant has completed initial study activities and is now randomised to one of the trial’s arms.

A photograph of the chief investigator and research nurses for the LEGEND-D trial © OCDEM
LEGEND-D clinical site research team

The LEGEND-D trial aims to find ways to prevent low blood sugar levels (hypoglycaemia) in type 1 diabetes. It will use  oral diabetic medications, which are normally used to treat type 2 diabetes, in people with type 1 diabetes. Researchers will find out whether administering these medications at smaller doses than normally prescribed could help prevent hypoglycaemia. We will recruit 20 participants with type 1 diabetes and 10 participants without diabetes.

If you are interested in taking part in this trial and wish to know more, please contact the research team at legend-d@ocdem.ox.ac.uk or cru@ocdem.ox.ac.uk.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories